Remove Clinical Trials Remove DEA Remove History Remove Marijuana
article thumbnail

ASA offers solution to DOJ research block: Our comments on the DEA’s proposed rules

Americans for Safe Access

On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.

article thumbnail

Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators

NORML

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.

DEA 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Medical Marijuana and Cannabidiol Research Expansion Act Has Passed

Veriheal

President Joe Biden has officially signed a marijuana research bill into law. This makes history by enacting the first piece of standalone federal cannabis reform legislation in U.S. 8454, the “Medical Marijuana and Cannabidiol Research Expansion Act,” has been passed. The law gives the U.S. The law gives the U.S.

article thumbnail

Bank of America Shuts Down Cannabis Research Facility Account

Cannabis Law Report

Bank of America (BoA) is reportedly terminating its banking relationship with Scottsdale Research Institute (SRI), a DEA-registered facility that carries out important marijuana research. So, given the history and credibility of the Institute, why did BoA terminate the 10-year banking relationship with SRI?

Banking 52
article thumbnail

DMT Therapy: Coming to a Clinic Near You?

Canna Law Blog

DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. So according to the DEA, its abuse potential is high and it has no medical use. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer.

Therapy 88
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history.

article thumbnail

MAPS Organization Granted $12.9 Million to Study Cannabis and PTSD •

SpeedWeed

The grant comes from Michigan’s 2021 Veteran Marijuana Research Grant Program , and is funded by the state’s recreational cannabis taxes. With a goal of determining the “the efficacy of marijuana in treating the medical conditions of United States armed services veterans and preventing veteran suicide.”. MAPS Makes History.